• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制性 ART 期间 HIV-1 储库大小和长期动力学的决定因素。

Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART.

机构信息

Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, 8091, Zurich, Switzerland.

Institute of Medical Virology, University of Zurich, 8057, Zurich, Switzerland.

出版信息

Nat Commun. 2019 Jul 19;10(1):3193. doi: 10.1038/s41467-019-10884-9.

DOI:10.1038/s41467-019-10884-9
PMID:31324762
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6642170/
Abstract

The HIV-1 reservoir is the major hurdle to a cure. We here evaluate viral and host characteristics associated with reservoir size and long-term dynamics in 1,057 individuals on suppressive antiretroviral therapy for a median of 5.4 years. At the population level, the reservoir decreases with diminishing differences over time, but increases in 26.6% of individuals. Viral blips and low-level viremia are significantly associated with slower reservoir decay. Initiation of ART within the first year of infection, pretreatment viral load, and ethnicity affect reservoir size, but less so long-term dynamics. Viral blips and low-level viremia are thus relevant for reservoir and cure studies.

摘要

HIV-1 储存库是治愈的主要障碍。我们在此评估了在中位数为 5.4 年的时间内接受抑制性抗逆转录病毒治疗的 1057 个人中与储存库大小和长期动态相关的病毒和宿主特征。在人群水平上,随着时间的推移,储存库的差异逐渐减少,但仍有 26.6%的个体的储存库增加。病毒突增和低水平病毒血症与储存库衰减速度较慢显著相关。感染后第一年开始接受 ART、治疗前病毒载量和种族影响储存库大小,但对长期动态的影响较小。因此,病毒突增和低水平病毒血症与储存库和治愈研究相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da8c/6642170/75dcbfab5214/41467_2019_10884_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da8c/6642170/0f257a624e57/41467_2019_10884_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da8c/6642170/c07cc0d1cb59/41467_2019_10884_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da8c/6642170/6ba6f0b7becd/41467_2019_10884_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da8c/6642170/75dcbfab5214/41467_2019_10884_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da8c/6642170/0f257a624e57/41467_2019_10884_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da8c/6642170/c07cc0d1cb59/41467_2019_10884_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da8c/6642170/6ba6f0b7becd/41467_2019_10884_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da8c/6642170/75dcbfab5214/41467_2019_10884_Fig4_HTML.jpg

相似文献

1
Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART.抑制性 ART 期间 HIV-1 储库大小和长期动力学的决定因素。
Nat Commun. 2019 Jul 19;10(1):3193. doi: 10.1038/s41467-019-10884-9.
2
Transient viremia, plasma viral load, and reservoir replenishment in HIV-infected patients on antiretroviral therapy.接受抗逆转录病毒治疗的HIV感染患者的短暂病毒血症、血浆病毒载量和储存库补充
J Acquir Immune Defic Syndr. 2007 Aug 15;45(5):483-93. doi: 10.1097/QAI.0b013e3180654836.
3
Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy.潜伏感染细胞激活的建模:病毒及潜伏储存库的持续存在,以及高效抗逆转录病毒治疗的HIV感染患者中的病毒波动
PLoS Comput Biol. 2009 Oct;5(10):e1000533. doi: 10.1371/journal.pcbi.1000533. Epub 2009 Oct 16.
4
Stochastic population switch may explain the latent reservoir stability and intermittent viral blips in HIV patients on suppressive therapy.随机群体转换可能解释了接受抑制性治疗的HIV患者中潜伏病毒库的稳定性和间歇性病毒波动。
J Theor Biol. 2014 Nov 7;360:137-148. doi: 10.1016/j.jtbi.2014.06.042. Epub 2014 Jul 10.
5
Viral blips during suppressive antiretroviral treatment are associated with high baseline HIV-1 RNA levels.在抗逆转录病毒治疗抑制期出现的病毒波动与高基线HIV-1 RNA水平相关。
BMC Infect Dis. 2016 Jun 21;16:305. doi: 10.1186/s12879-016-1628-6.
6
HIV-1 non-R5 tropism correlates with a larger size of the cellular viral reservoir and a detectable residual viremia in patients under suppressive ART.HIV-1 非 R5 嗜性与细胞病毒储存库的更大规模以及抑制性 ART 下患者可检测到的残余病毒血症相关。
J Clin Virol. 2018 Jun;103:57-62. doi: 10.1016/j.jcv.2018.03.013. Epub 2018 Apr 2.
7
HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy.接受联合治疗且病毒载量<50拷贝/毫升的儿童和成人的HIV-1耐药性概况。
JAMA. 2001 Jul 11;286(2):196-207. doi: 10.1001/jama.286.2.196.
8
CD4 T cell nadir independently predicts the magnitude of the HIV reservoir after prolonged suppressive antiretroviral therapy.CD4 T 细胞最低点独立预测长期抑制性抗逆转录病毒治疗后 HIV 储存库的大小。
J Clin Virol. 2012 Jan;53(1):29-32. doi: 10.1016/j.jcv.2011.09.018. Epub 2011 Oct 22.
9
Dynamics of intermittent viremia during highly active antiretroviral therapy in patients who initiate therapy during chronic versus acute and early human immunodeficiency virus type 1 infection.在慢性与急性及早期1型人类免疫缺陷病毒感染期间开始接受治疗的患者中,高效抗逆转录病毒治疗期间间歇性病毒血症的动态变化。
J Virol. 2004 Oct;78(19):10566-73. doi: 10.1128/JVI.78.19.10566-10573.2004.
10
Modeling HIV persistence, the latent reservoir, and viral blips.建立 HIV 持续性、潜伏库和病毒爆发模型。
J Theor Biol. 2009 Sep 21;260(2):308-31. doi: 10.1016/j.jtbi.2009.06.011. Epub 2009 Jun 17.

引用本文的文献

1
Duplex digital PCR assay on microfluidic chamber arrays for total HIV DNA reservoir quantification in persons with HIV.用于定量检测HIV感染者体内总HIV DNA储存库的微流控芯片阵列双链数字PCR检测法
Sci Rep. 2025 Aug 27;15(1):31658. doi: 10.1038/s41598-025-17392-5.
2
Low-level viremia and subsequent virologic failure among people living with HIV: a retrospective cohort study in China.中国HIV感染者中的低水平病毒血症及后续病毒学失败:一项回顾性队列研究
BMC Infect Dis. 2025 Aug 14;25(1):1024. doi: 10.1186/s12879-025-11395-3.
3
From network biology to immunity: potential longitudinal biomarkers for targeting the network topology of the HIV reservoir.

本文引用的文献

1
The role of integration and clonal expansion in HIV infection: live long and prosper.整合与克隆性扩张在 HIV 感染中的作用:生生不息。
Retrovirology. 2018 Oct 23;15(1):71. doi: 10.1186/s12977-018-0448-8.
2
Virological remission after antiretroviral therapy interruption in female African HIV seroconverters.抗逆转录病毒治疗中断后女性非洲 HIV 血清转化者的病毒学缓解。
AIDS. 2019 Feb 1;33(2):185-197. doi: 10.1097/QAD.0000000000002044.
3
No Effect of Pegylated Interferon-α on Total HIV-1 DNA Load in HIV-1/HCV Coinfected Patients.聚乙二醇干扰素-α 对 HIV-1/HCV 共感染患者的 HIV-1 总 DNA 载量无影响。
从网络生物学到免疫:用于靶向HIV储存库网络拓扑结构的潜在纵向生物标志物。
J Transl Med. 2025 Aug 13;23(1):906. doi: 10.1186/s12967-025-06919-z.
4
Proviruses in CD4 T cells reactive to autologous antigens contribute to nonsuppressible HIV-1 viremia.对自身抗原产生反应的CD4 T细胞中的前病毒会导致无法抑制的HIV-1病毒血症。
Sci Transl Med. 2025 Aug 13;17(811):eadu4643. doi: 10.1126/scitranslmed.adu4643.
5
Differential HIV-1 Proviral Defects in Children vs. Adults on Antiretroviral Therapy.接受抗逆转录病毒治疗的儿童与成人中HIV-1前病毒的差异缺陷
Viruses. 2025 Jul 9;17(7):961. doi: 10.3390/v17070961.
6
Current insight into HIV-1 persistence from single-cell transcriptome profiling in acutely treated cohorts of infection.急性感染治疗队列单细胞转录组分析对HIV-1持续存在的当前见解。
Curr Opin HIV AIDS. 2025 Jul 7. doi: 10.1097/COH.0000000000000962.
7
The role of Nef in the long-term persistence of the replication-competent HIV reservoir in South African women.Nef在南非女性体内具有复制能力的HIV病毒库长期存留中的作用。
J Virol. 2025 Jun 24:e0021725. doi: 10.1128/jvi.00217-25.
8
Differential HIV-1 Proviral Defects in Children vs. Adults on Antiretroviral Therapy.接受抗逆转录病毒治疗的儿童与成人中HIV-1前病毒的差异缺陷
bioRxiv. 2025 May 27:2025.05.23.655786. doi: 10.1101/2025.05.23.655786.
9
Combined dendritic cell and anti-TIGIT immunotherapy potentiates adaptive NK cells against HIV-1.联合树突状细胞和抗TIGIT免疫疗法增强适应性自然杀伤细胞对抗HIV-1的能力。
EMBO Mol Med. 2025 Jun 5. doi: 10.1038/s44321-025-00255-x.
10
Applications and limitations of the passenger hypothesis for HIV reservoir persistence and cure.“乘客”假说在HIV病毒库持久性及治愈方面的应用与局限性
J Virol. 2025 Jul 22;99(7):e0071425. doi: 10.1128/jvi.00714-25. Epub 2025 Jun 4.
J Infect Dis. 2018 May 25;217(12):1883-1888. doi: 10.1093/infdis/jiy131.
4
Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane.携带复制型 HIV-1 的扩增细胞克隆持续存在、增加和减少。
Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):E2575-E2584. doi: 10.1073/pnas.1720665115. Epub 2018 Feb 26.
5
HIV evolution and diversity in ART-treated patients.抗逆转录病毒治疗患者中的 HIV 进化和多样性。
Retrovirology. 2018 Jan 30;15(1):14. doi: 10.1186/s12977-018-0395-4.
6
Blood biomarkers of expressed and inducible HIV-1.HIV-1 的表达和诱导型血液生物标志物。
AIDS. 2018 Mar 27;32(6):699-708. doi: 10.1097/QAD.0000000000001748.
7
Long-term Therapeutic Impact of the Timing of Antiretroviral Therapy in Patients Diagnosed With Primary Human Immunodeficiency Virus Type 1 Infection.原发性人类免疫缺陷病毒 1 型感染患者抗逆转录病毒治疗时机对长期疗效的影响。
Clin Infect Dis. 2018 May 2;66(10):1519-1527. doi: 10.1093/cid/cix1068.
8
Landscape review of current HIV 'kick and kill' cure research - some kicking, not enough killing.当前艾滋病病毒“踢杀”疗法研究的全景综述——有所进展,但成效不足。
BMC Infect Dis. 2017 Aug 29;17(1):595. doi: 10.1186/s12879-017-2683-3.
9
Clonal expansion of genome-intact HIV-1 in functionally polarized Th1 CD4+ T cells.功能极化的Th1 CD4 + T细胞中基因组完整的HIV-1的克隆扩增。
J Clin Invest. 2017 Jun 30;127(7):2689-2696. doi: 10.1172/JCI93289. Epub 2017 Jun 19.
10
Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies.1996 年至 2013 年开始抗逆转录病毒治疗的 HIV 阳性患者的生存情况:队列研究的协作分析。
Lancet HIV. 2017 Aug;4(8):e349-e356. doi: 10.1016/S2352-3018(17)30066-8. Epub 2017 May 10.